Evidence map›Paper›PMID 38646483›Full record

ArticlePeerJ2024

Cytokine profiles of mild-to-moderate SARS-CoV-2 infected and recovered pre-vaccinated individuals residing in Indonesia.

Ni Luh Ayu Megasari, Siti Qamariyah Khairunisa, Radita Yuniar Arizandy, I Komang Evan Wijaksana, Citrawati Dyah Kencono Wungu

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Association ofDiseases (Basel, Switzerland) · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Ni Luh Ayu MegasariInstitute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Siti Qamariyah KhairunisaInstitute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Radita Yuniar ArizandyInstitute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
I Komang Evan WijaksanaDepartment of Periodontology, Faculty of Dental Medicine, Airlangga University, Surabaya, Indonesia.
Citrawati Dyah Kencono WunguInstitute of Tropical Disease, Airlangga University, Surabaya, Indonesia.
Airlangga University · ID

Funding

Directorate of Research, Technology and Community Service, Ministry of Education, Culture, Research, and Technology, Indonesia
6 · The paper itself

Abstract

Background: Accumulating evidence suggests the involvement of cytokine-mediated inflammation, in clinical severity and death related to SARS-CoV-2 infection, especially among pre-vaccinated individuals. An increased risk of death was also described among SARS-CoV-2 recovered individuals, which might be correlated with prolonged inflammatory responses. Despite being among the countries with the highest cumulative deaths due to COVID-19, evidence regarding cytokine profiles among SARS-CoV-2 infected and recovered pre-vaccinated individuals in Indonesia is scarce. Thus, this study aimed to describe the cytokines profiles of pre-vaccinated individuals residing in Indonesia, with mild-to-moderate SARS-CoV-2 infection and those who recovered. Methods: Sixty-one sera from 24 hospitalized patients with mild-to-moderate SARS-CoV-2 infection, 24 individuals recovered from asymptomatic-to-moderate SARS-CoV-2 infection, and 13 healthy controls unexposed to SARS-CoV-2 were used in this study. Quantification of serum cytokine levels, including IL-6, IL-8, IP-10, TNF- Results: The levels of IL-8 along with CCL-2 and CCL-4, were significantly higher ( Conclusion: IL-8, CCL-2, and CCL-4 were significantly elevated in pre-vaccinated Indonesian individuals with mild-to-moderate SARS-CoV-2 infection and those who recovered. The cytokine profiles described in this study might indicate inflammatory responses not only among SARS-CoV-2 infected, but also recovered individuals.

Indexed as

COVID-19CytokinesSARS-CoV-2AdultCase-Control StudiesCOVID-19 VaccinesFemaleHumansIndonesiaMaleMiddle AgedSeverity of Illness IndexYoung AdultCOVID-19 VaccinesCytokinesCOVID-19Inflammatory cytokinesMild-to-moderate infectionSARS-CoV-2Vaccination

Identifiers

PMID38646483
PMCPMC11032655
OpenAlexW4394925810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.